Inhibition of dermatophytes by the antimicrobial peptides human β-defensin-2, ribonuclease 7 and psoriasin.

Previous studies have described some antibacterial effects of antimicrobial peptides (AMPs) expressed in human skin, but little is known about their possible activity against dermatophytes. Therefore we have tested the effects of human β-defensin 2 (hBD-2), ribonuclease 7 (RNase 7) and psoriasin on the in vitro growth of four dermatophyte species. Germinating conidia of Trichophyton rubrum, T. mentagrophytes, Microsporum canis and Epidermophyton floccosum were exposed in vitro to hBD-2, RNase 7, psoriasin and fluconazole. Subsequent fungal growth was measured photometrically over 168 hours. All AMPs significantly inhibited fungal growth, with the degree of inhibition dependent on the dermatophyte species and the specific AMP. E. floccosum was found to be the most susceptible species in that it was markedly suppressed by all AMPs, whereas M. canis was inhibited only by psoriasin. Overall, psoriasin was the most effective AMP and had even stronger inhibitory effects on some dermatophytes than fluconazole. Our findings show that AMPs expressed in human skin can, in principal, inhibit the growth of dermatophytes in vitro. Therefore the question whether AMPs are relevant for human protection against tineas is justified and should be addressed by investigating their role in vivo.

[1]  C. Bogdan,et al.  Diagnosis and therapy of cutaneous and mucocutaneous Leishmaniasis in Germany , 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[2]  R. Gläser Research in practice: Antimicrobial peptides of the skin , 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[3]  J. Brasch Pathogenesis of tinea , 2010, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[4]  J. Brasch Current knowledge of host response in human tinea , 2009, Mycoses.

[5]  R. Nagaraj,et al.  Antifungal Activities of Human Beta-Defensins HBD-1 to HBD-3 and Their C-Terminal Analogs Phd1 to Phd3 , 2008, Antimicrobial Agents and Chemotherapy.

[6]  Guoxing Wang,et al.  Antimicrobial host defense in the upper gastrointestinal tract , 2008, European journal of gastroenterology & hepatology.

[7]  M. Kleine,et al.  Barrier function, epidermal differentiation, and human beta-defensin 2 expression in tinea corporis. , 2007, The Journal of investigative dermatology.

[8]  S. Vylkova,et al.  Human β-Defensins Kill Candida albicans in an Energy-Dependent and Salt-Sensitive Manner without Causing Membrane Disruption , 2006, Antimicrobial Agents and Chemotherapy.

[9]  J. Schröder,et al.  Antimicrobial skin peptides and proteins , 2006, Cellular and Molecular Life Sciences CMLS.

[10]  M. Ghannoum,et al.  Human Beta-defensins: Differential Activity against Candidal Species and Regulation by Candida albicans , 2005, Journal of dental research.

[11]  J. Schröder,et al.  Psoriatic scales: a promising source for the isolation of human skin‐derived antimicrobial proteins , 2005, Journal of leukocyte biology.

[12]  Maria José Figueras,et al.  Atlas of clinical fungi. , 2005 .

[13]  J. Schröder,et al.  Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection , 2005, Nature Immunology.

[14]  P. Lachmann,et al.  The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins , 2004, Immunology.

[15]  J. Schröder,et al.  RNase 7, a Novel Innate Immune Defense Antimicrobial Protein of Healthy Human Skin* , 2002, The Journal of Biological Chemistry.

[16]  C. Brissette,et al.  Treponema denticola Is Resistant to Human β-Defensins , 2002, Infection and Immunity.

[17]  Christina H. Park,et al.  Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. , 2002, The Journal of investigative dermatology.

[18]  C. Brissette,et al.  Treponema denticola is resistant to human beta-defensins. , 2002, Infection and immunity.

[19]  J. Schröder,et al.  Isolation and Characterization of Human β-Defensin-3, a Novel Human Inducible Peptide Antibiotic* , 2001, The Journal of Biological Chemistry.

[20]  M. Watson,et al.  Burkholderia cepacia is resistant to the antimicrobial activity of airway epithelial cells. , 1999, Immunopharmacology.

[21]  J. Nyborg,et al.  Zinc-binding site of an S100 protein revealed. Two crystal structures of Ca2+-bound human psoriasin (S100A7) in the Zn2+-loaded and Zn2+-free states. , 1999, Biochemistry.

[22]  J. Schröder,et al.  A peptide antibiotic from human skin , 1997, Nature.

[23]  A. Padhye,et al.  Dermatophytes: gross and microscopic. , 1996, Dermatologic clinics.

[24]  R. Summerbell,et al.  The dermatophytes , 1995, Clinical microbiology reviews.